LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 21

Search options

  1. Article: Mucosal Tuft Cell Density Is Increased in Diarrhea-Predominant Irritable Bowel Syndrome Colonic Biopsies.

    Aigbologa, Jessica / Connolly, Maeve / Buckley, Julliette M / O'Malley, Dervla

    Frontiers in psychiatry

    2020  Volume 11, Page(s) 436

    Abstract: Tuft cells are rare chemosensory sentinels found in the gut epithelium. When triggered by helminth infection, tuft cells secrete interleukin-25 (IL-25) basolaterally and subsequently evoke an immune response. Irritable bowel syndrome (IBS) is a common ... ...

    Abstract Tuft cells are rare chemosensory sentinels found in the gut epithelium. When triggered by helminth infection, tuft cells secrete interleukin-25 (IL-25) basolaterally and subsequently evoke an immune response. Irritable bowel syndrome (IBS) is a common and heterogeneous disorder characterized by bowel dysfunction and visceral pain sensitivity. Dysfunctional gut-brain communication and immune activation contribute to the pathophysiology of this disorder. The study aims were to investigate changes in tuft cell density in non-post-infectious IBS patients. Immunofluorescent labeling of DCLK1-positive tuft cells was carried out in mucosal biopsies from the distal colons of diarrhea and constipation-predominant IBS patients and healthy controls. Tuft cell numbers were also assessed in animal models. Concentrations of interleukin-25 (IL-25) secreted from colonic biopsies and in plasma samples were analyzed using an immunoassay. The density of tuft cells was increased in diarrhea-but not constipation-predominant IBS patient colonic biopsies. Biopsy secretions and plasma concentrations of IL-25 were elevated in diarrhea-but not constipation-predominant IBS participants. Tuft cell hyperplasia was detected in a rat model of IBS but not in mice exposed to chronic stress. Tuft cell hyperplasia is an innate immune response to helminth exposure. However, the patients with diarrhea-predominant IBS have not reported any incidents of enteric infection. Moreover, rats exhibiting IBS-like symptoms displayed increased tuft cell density but were not exposed to helminths. Our findings suggest that factors other than helminth exposure or chronic stress lead to tuft cell hyperplasia in IBS colonic biopsies.
    Language English
    Publishing date 2020-05-15
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2564218-2
    ISSN 1664-0640
    ISSN 1664-0640
    DOI 10.3389/fpsyt.2020.00436
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Aromatase inhibition to decrease background parenchymal enhancement: premedication before magnetic resonance imaging?

    Buckley, Julliette M / Hughes, Kevin S

    Menopause (New York, N.Y.)

    2012  Volume 19, Issue 4, Page(s) 385–386

    MeSH term(s) Aromatase Inhibitors ; Breast/pathology ; Female ; Humans ; Image Enhancement/methods ; Magnetic Resonance Imaging/methods ; Postmenopause
    Chemical Substances Aromatase Inhibitors
    Language English
    Publishing date 2012-04
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 1205262-0
    ISSN 1530-0374 ; 1072-3714
    ISSN (online) 1530-0374
    ISSN 1072-3714
    DOI 10.1097/gme.0b013e31824af478
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: GHSR-1 agonist sensitizes rat colonic intrinsic and extrinsic neurons to exendin-4: A role in the manifestation of postprandial gastrointestinal symptoms in irritable bowel syndrome?

    Buckley, Maria M / O'Brien, Rebecca / Buckley, Julliette M / O'Malley, Dervla

    Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

    2019  Volume 31, Issue 10, Page(s) e13684

    Abstract: Background: Patients with irritable bowel syndrome (IBS) may experience postprandial symptom exacerbation. Nutrients stimulate intestinal release of glucagon-like peptide 1 (GLP-1), an incretin hormone with known gastrointestinal effects. However, prior ...

    Abstract Background: Patients with irritable bowel syndrome (IBS) may experience postprandial symptom exacerbation. Nutrients stimulate intestinal release of glucagon-like peptide 1 (GLP-1), an incretin hormone with known gastrointestinal effects. However, prior to the postprandial rise in GLP-1, levels of the hunger hormone, ghrelin, peak. The aims of this study were to determine if ghrelin sensitizes colonic intrinsic and extrinsic neurons to the stimulatory actions of a GLP-1 receptor agonist, and if this differs in a rat model of IBS.
    Methods: Calcium imaging of enteric neurons was compared between Sprague Dawley and Wistar Kyoto rats. Colonic contractile activity and vagal nerve recordings were also compared between strains.
    Key results: Circulating GLP-1 concentrations differ between IBS subtypes. Mechanistically, we have provided evidence that calcium responses evoked by exendin-4, a GLP-1 receptor agonist, are potentiated by a ghrelin receptor (GHSR-1) agonist, in both submucosal and myenteric neurons. Although basal patterns of colonic contractility varied between Sprague Dawley and Wister Kyoto rats, the capacity of exendin-4 to alter smooth muscle function was modified by a GHSR-1 agonist in both strains. Gut-brain signaling via GLP-1-mediated activation of vagal afferents was also potentiated by the GHSR-1 agonist.
    Conclusions & inferences: These findings support a temporal interaction between ghrelin and GLP-1, where the preprandial peak in ghrelin may temporarily sensitize colonic intrinsic and extrinsic neurons to the neurostimulatory actions of GLP-1. While the sensitizing effects of the GHSR-1 agonist were identified in both rat strains, in the rat model of IBS, underlying contractile activity was aberrant.
    MeSH term(s) Animals ; Colon/drug effects ; Colon/innervation ; Colon/metabolism ; Constipation/metabolism ; Constipation/physiopathology ; Diarrhea/metabolism ; Diarrhea/physiopathology ; Electrophysiological Phenomena ; Enteric Nervous System/cytology ; Enteric Nervous System/drug effects ; Exenatide/pharmacology ; Ghrelin/metabolism ; Glucagon-Like Peptide 1/metabolism ; Glucagon-Like Peptide-1 Receptor/agonists ; Humans ; Incretins/pharmacology ; Irritable Bowel Syndrome/metabolism ; Irritable Bowel Syndrome/physiopathology ; Muscle Contraction/drug effects ; Muscle, Smooth/drug effects ; Neurons/drug effects ; Neurons/metabolism ; Rats ; Rats, Inbred WKY ; Rats, Sprague-Dawley ; Receptors, Ghrelin/agonists ; Vagus Nerve/drug effects ; Vagus Nerve/metabolism
    Chemical Substances Ghrelin ; Glucagon-Like Peptide-1 Receptor ; Incretins ; Receptors, Ghrelin ; Glucagon-Like Peptide 1 (89750-14-1) ; Exenatide (9P1872D4OL)
    Language English
    Publishing date 2019-07-16
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1186328-6
    ISSN 1365-2982 ; 1350-1925
    ISSN (online) 1365-2982
    ISSN 1350-1925
    DOI 10.1111/nmo.13684
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Glucagon-Like Peptide-1 Secreting L-Cells Coupled to Sensory Nerves Translate Microbial Signals to the Host Rat Nervous System.

    Buckley, Maria M / O'Brien, Rebecca / Brosnan, Eilish / Ross, R Paul / Stanton, Catherine / Buckley, Julliette M / O'Malley, Dervla

    Frontiers in cellular neuroscience

    2020  Volume 14, Page(s) 95

    Abstract: An intact gut epithelium preserves the immunological exclusion of "non-self" entities in the external environment of the gut lumen. Nonetheless, information flows continuously across this interface, with the host immune, endocrine, and neural systems all ...

    Abstract An intact gut epithelium preserves the immunological exclusion of "non-self" entities in the external environment of the gut lumen. Nonetheless, information flows continuously across this interface, with the host immune, endocrine, and neural systems all involved in monitoring the luminal environment of the gut. Both pathogenic and commensal gastrointestinal (GI) bacteria can modulate centrally-regulated behaviors and brain neurochemistry and, although the vagus nerve has been implicated in the microbiota-gut-brain signaling axis, the cellular and molecular machinery that facilitates this communication is unclear. Studies were carried out in healthy Sprague-Dawley rats to understand cross-barrier communication in the absence of disease. A novel colonic-nerve electrophysiological technique was used to examine gut-to-brain vagal signaling by bacterial products. Calcium imaging and immunofluorescent labeling were used to explore the activation of colonic submucosal neurons by bacterial products. The findings demonstrate that the neuromodulatory molecule, glucagon-like peptide-1 (GLP-1), secreted by colonic enteroendocrine L-cells in response to the bacterial metabolite, indole, stimulated colonic vagal afferent activity. At a local level indole modified the sensitivity of submucosal neurons to GLP-1. These findings elucidate a cellular mechanism by which sensory L-cells act as cross-barrier signal transducers between microbial products in the gut lumen and the host peripheral nervous system.
    Language English
    Publishing date 2020-04-30
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2452963-1
    ISSN 1662-5102
    ISSN 1662-5102
    DOI 10.3389/fncel.2020.00095
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Imaging of the complications of acute pancreatitis.

    O'Connor, Owen J / Buckley, Julliette M / Maher, Michael M

    AJR. American journal of roentgenology

    2011  Volume 197, Issue 3, Page(s) W375–81

    MeSH term(s) Diagnostic Imaging ; Humans ; Pancreatitis/complications ; Pancreatitis/epidemiology ; Pancreatitis/physiopathology ; Severity of Illness Index
    Language English
    Publishing date 2011-09
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 82076-3
    ISSN 1546-3141 ; 0361-803X ; 0092-5381
    ISSN (online) 1546-3141
    ISSN 0361-803X ; 0092-5381
    DOI 10.2214/AJR.10.4339
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Doctor, would you drain this collection?

    O'Connor, Owen J / Buckley, Julliette M / Arellano, Ronald S

    Journal of vascular and interventional radiology : JVIR

    2012  Volume 23, Issue 4, Page(s) 519

    MeSH term(s) Collagen/adverse effects ; Drainage ; Extravasation of Diagnostic and Therapeutic Materials/diagnostic imaging ; Extravasation of Diagnostic and Therapeutic Materials/etiology ; Extravasation of Diagnostic and Therapeutic Materials/surgery ; Humans ; Liver/diagnostic imaging ; Male ; Middle Aged ; Tomography, X-Ray Computed
    Chemical Substances Alloderm ; Collagen (9007-34-5)
    Language English
    Publishing date 2012-04
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1137756-2
    ISSN 1535-7732 ; 1051-0443
    ISSN (online) 1535-7732
    ISSN 1051-0443
    DOI 10.1016/j.jvir.2012.01.054
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Reassessing risk models for atypical hyperplasia: age may not matter.

    Mazzola, Emanuele / Coopey, Suzanne B / Griffin, Molly / Polubriaginof, Fernanda / Buckley, Julliette M / Parmigiani, Giovanni / Garber, Judy E / Smith, Barbara L / Gadd, Michele A / Specht, Michelle C / Guidi, Anthony / Hughes, Kevin S

    Breast cancer research and treatment

    2017  Volume 165, Issue 2, Page(s) 285–291

    Abstract: Purpose: The aim of this study was to investigate the influence of age at diagnosis of atypical hyperplasia ("atypia", ductal [ADH], lobular [ALH], or severe ADH) on the risk of developing subsequent invasive breast cancer or ductal carcinoma in situ ( ... ...

    Abstract Purpose: The aim of this study was to investigate the influence of age at diagnosis of atypical hyperplasia ("atypia", ductal [ADH], lobular [ALH], or severe ADH) on the risk of developing subsequent invasive breast cancer or ductal carcinoma in situ (DCIS).
    Methods: Using standard survival analysis methods, we retrospectively analyzed 1353 women not treated with chemoprevention among a cohort of 2370 women diagnosed with atypical hyperplasia to determine the risk relationship between age at diagnosis and subsequent breast cancer.
    Results: For all atypia diagnoses combined, our cohort showed a 5-, 10-, and 15-year risk of invasive breast cancer or DCIS of 0.56, 1.25, and 1.30, respectively, with no significant difference in the (65,75] year age group. For women aged (35,75] years, we observed no significant difference in the 15-year risk of invasive breast cancer or DCIS after atypical hyperplasia, although the baseline risk for a 40-year-old woman is approximately 1/8 the risk of a 70-year-old woman. The risks associated with invasive breast cancer or DCIS for women in our cohort diagnosed with ADH, severe ADH, or ALH, regardless of age, were 7.6% (95% CI 5.9-9.3%) at 5 years, 25.1% (20.7-29.2%) at 10 years, and 40.1% (32.8-46.6%) at 15 years.
    Conclusion: In contrast to current risk prediction models (e.g., Gail, Tyrer-Cuzick) which assume that the risk of developing breast cancer increases in relation to age at diagnosis of atypia, we found the 15-year cancer risk in our cohort was not significantly different for women between the ages of 35 (excluded) and 75. This implies that the "hits" received by the breast tissue along the "high-risk pathway" to cancer might possibly supersede other factors such as age.
    MeSH term(s) Adult ; Age Factors ; Aged ; Aged, 80 and over ; Biomarkers ; Breast/pathology ; Breast Neoplasms/diagnosis ; Breast Neoplasms/epidemiology ; Female ; Humans ; Hyperplasia ; Kaplan-Meier Estimate ; Middle Aged ; Neoplasm Grading ; Precancerous Conditions/epidemiology ; Precancerous Conditions/pathology ; Prognosis ; Risk Assessment
    Chemical Substances Biomarkers
    Language English
    Publishing date 2017-06-06
    Publishing country Netherlands
    Document type Journal Article ; Meta-Analysis ; Review
    ZDB-ID 604563-7
    ISSN 1573-7217 ; 0167-6806
    ISSN (online) 1573-7217
    ISSN 0167-6806
    DOI 10.1007/s10549-017-4320-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: ST2 negatively regulates TLR2 signaling, but is not required for bacterial lipoprotein-induced tolerance.

    Liu, Jinghua / Buckley, Julliette M / Redmond, H Paul / Wang, Jiang Huai

    Journal of immunology (Baltimore, Md. : 1950)

    2010  Volume 184, Issue 10, Page(s) 5802–5808

    Abstract: Activation of TLR signaling is critical for host innate immunity against bacterial infection. Previous studies reported that the ST2 receptor, a member of the Toll/IL-1 receptor superfamily, functions as a negative regulator of TLR4 signaling and ... ...

    Abstract Activation of TLR signaling is critical for host innate immunity against bacterial infection. Previous studies reported that the ST2 receptor, a member of the Toll/IL-1 receptor superfamily, functions as a negative regulator of TLR4 signaling and maintains LPS tolerance. However, it is undetermined whether ST2 negatively regulates TLR2 signaling and furthermore, whether a TLR2 agonist, bacterial lipoprotein (BLP)-induced tolerance is dependent on ST2. In this study, we show that BLP stimulation-induced production of proinflammatory cytokines and immunocomplex formation of TLR2-MyD88 and MyD88-IL-1R-associated kinase (IRAK) were significantly enhanced in ST2-deficient macrophages compared with those in wild-type controls. Furthermore, overexpression of ST2 dose-dependently attenuated BLP-induced NF-kappaB activation, suggesting a negative regulatory role of ST2 in TLR2 signaling. A moderate but significantly attenuated production of TNF-alpha and IL-6 on a second BLP stimulation was observed in BLP-pretreated, ST2-deficient macrophages, which is associated with substantially reduced IRAK-1 protein expression and downregulated TLR2-MyD88 and MyD88-IRAK immunocomplex formation. ST2-deficient mice, when pretreated with a nonlethal dose of BLP, benefitted from an improved survival against a subsequent lethal BLP challenge, indicating BLP tolerance develops in the absence of the ST2 receptor. Taken together, our results demonstrate that ST2 acts as a negative regulator of TLR2 signaling, but is not required for BLP-induced tolerance.
    MeSH term(s) Animals ; Bacterial Proteins/physiology ; Cells, Cultured ; Down-Regulation/genetics ; Down-Regulation/immunology ; Humans ; Immune Tolerance/genetics ; Interleukin-1 Receptor-Like 1 Protein ; Lipoproteins/physiology ; Macrophages, Peritoneal/immunology ; Macrophages, Peritoneal/metabolism ; Mice ; Mice, Inbred BALB C ; Mice, Knockout ; Receptors, Interleukin/deficiency ; Receptors, Interleukin/genetics ; Receptors, Interleukin/physiology ; Signal Transduction/genetics ; Signal Transduction/immunology ; Toll-Like Receptor 2/agonists ; Toll-Like Receptor 2/antagonists & inhibitors ; Toll-Like Receptor 2/physiology
    Chemical Substances Bacterial Proteins ; Il1rl1 protein, mouse ; Interleukin-1 Receptor-Like 1 Protein ; Lipoproteins ; Receptors, Interleukin ; Tlr2 protein, mouse ; Toll-Like Receptor 2
    Language English
    Publishing date 2010-05-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.0904127
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Cellular reprogramming by gram-positive bacterial components: a review.

    Buckley, Julliette M / Wang, Jiang Huai / Redmond, H Paul

    Journal of leukocyte biology

    2006  Volume 80, Issue 4, Page(s) 731–741

    Abstract: LPS tolerance has been the focus of extensive scientific and clinical research over the last several decades in an attempt to elucidate the sequence of changes that occur at a molecular level in tolerized cells. Tolerance to components of gram-positive ... ...

    Abstract LPS tolerance has been the focus of extensive scientific and clinical research over the last several decades in an attempt to elucidate the sequence of changes that occur at a molecular level in tolerized cells. Tolerance to components of gram-positive bacterial cell walls such as bacterial lipoprotein and lipoteichoic acid is a much lesser studied, although equally important, phenomenon. This review will focus on cellular reprogramming by gram-positive bacterial components and examines the alterations in cell surface receptor expression, changes in intracellular signaling, gene expression and cytokine production, and the phenomenon of cross-tolerance.
    MeSH term(s) Animals ; Cytokines/biosynthesis ; Cytokines/drug effects ; Gram-Positive Bacteria/immunology ; Humans ; Immune Tolerance/immunology ; Lipopolysaccharides/immunology ; Lipopolysaccharides/pharmacology ; Lipoproteins/pharmacology ; Receptors, Cell Surface/biosynthesis ; Receptors, Cell Surface/drug effects ; Receptors, Cell Surface/immunology ; Signal Transduction/drug effects ; Signal Transduction/immunology ; Teichoic Acids/pharmacology
    Chemical Substances Cytokines ; Lipopolysaccharides ; Lipoproteins ; Receptors, Cell Surface ; Teichoic Acids ; lipoteichoic acid (56411-57-5)
    Language English
    Publishing date 2006-10
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 605722-6
    ISSN 1938-3673 ; 0741-5400
    ISSN (online) 1938-3673
    ISSN 0741-5400
    DOI 10.1189/jlb.0506312
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger.

    Plichta, Jennifer K / Rai, Upahvan / Tang, Rong / Coopey, Suzanne B / Buckley, Julliette M / Gadd, Michele A / Specht, Michelle C / Hughes, Kevin S / Taghian, Alphonse G / Smith, Barbara L

    Annals of surgical oncology

    2016  Volume 23, Issue 10, Page(s) 3212–3220

    Abstract: Background: Young age at breast cancer diagnosis has been associated with increased risk of recurrence and mortality. We reevaluated this assumption in a large, modern cohort of women diagnosed with breast cancer at age ≤40 years.: Methods: We ... ...

    Abstract Background: Young age at breast cancer diagnosis has been associated with increased risk of recurrence and mortality. We reevaluated this assumption in a large, modern cohort of women diagnosed with breast cancer at age ≤40 years.
    Methods: We identified women with breast cancer at age ≤40 years at a single institution from 1996-2008. We assessed locoregional recurrence (LRR), distant recurrence, disease-free survival (DFS), and overall survival (OS), and correlated patient and tumor characteristics with outcomes.
    Results: We identified 584 women aged ≤40 years with breast cancer. Median age was 37 years, and median follow-up was 124 months; 61.5 % were stages 0-I and 38.5 % were stages II-III. Overall, 57.4 % had lumpectomies and 42.5 % mastectomies. DFS was 93 % at 5 years and 84.5 % at 10 years. OS was 93 % at 5 years and 86.5 % at 10 years. On multivariate analysis, worse DFS was associated with positive nodes (p = 0.002); worse OS was associated with larger tumor size (p = 0.042). When stratified by lumpectomy versus mastectomy, there were no significant differences in survival or recurrence. For lumpectomy patients, DFS was 96 % at 5 years and 88 % at 10 years; OS was 96 % at 5 years and 89 % at 10 years. For mastectomy patients, DFS was 89.5 % at 5 years and 79 % at 10 years; OS was 90 % at 5 years and 83 % at 10 years. Lumpectomy LRR rates were 1 % at 5 years and 4 % at 10 years. Mastectomy LRR rates were 3.5 % at 5 years and 8.7 % at 10 years.
    Conclusions: Outcomes for women with breast cancer at age ≤40 years have improved. Lumpectomy recurrence rates are low, suggesting that lumpectomy is oncologically safe for young breast cancer patients.
    MeSH term(s) Adult ; Age of Onset ; Breast Neoplasms/diagnosis ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Mastectomy, Segmental ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Staging ; Risk Factors ; Survival Rate ; Time Factors ; Tumor Burden ; Young Adult
    Language English
    Publishing date 2016-07-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1200469-8
    ISSN 1534-4681 ; 1068-9265
    ISSN (online) 1534-4681
    ISSN 1068-9265
    DOI 10.1245/s10434-016-5404-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top